Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10392434
Treating refractory migraine
granted -
US 10392432
Human antibodies to influenza hemagglutinin
granted -
US 10392430
Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 10392412
Platinum anticancer agents
granted -
US 10392391
Compounds useful as inhibitors of ATR kinase
granted -
US 10392386
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10392379
Hepatitis B core protein modulators
granted -
US 10392365
Antifungal compound process
granted -
US 10391175
BET bromodomain inhibitors and therapeutic methods using the same
granted -
US 10391170
Stable anti-OSMR antibody formulation
granted -
US 10391157
Materials and methods for producing improved lentiviral vector particles
granted -
US 10392368
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10391152
Methods of using a fixed dose of a clotting factor
granted -
US 10391143
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
granted -
US 10391116
Polyvalent RNA-nanoparticle compositions
granted -
US 10391112
Cationic polymers as co-drugs for chemotherapeutic agents
granted -
US 10391142
Biomarkers for painful intervertebral discs and methods of use thereof
granted -
US 10391098
Antisense antibacterial compounds and methods
granted -
US 10391097
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
granted -
US 10391095
DNA-PK inhibitors
granted -
US 10391093
Therapeutic compounds
granted -
US 10391075
Antiviral treatments
granted -
US 10392439
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
granted -
US 10391126
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.